A case series examining PTSD and depression symptom reductions over the course of a 2-week virtual intensive PTSD treatment program for veterans.

2021 ◽  
Author(s):  
Philip Held ◽  
Jennifer A. Coleman ◽  
Kelsey Petrey ◽  
Brian J. Klassen ◽  
Sarah Pridgen ◽  
...  
Keyword(s):  
Treatment Program ◽  
Case Series ◽  
Depression Symptom ◽  
Ptsd Treatment

scholarly journals Exposure therapy for PTSD during pregnancy: a feasibility, acceptability, and case series study of Narrative Exposure Therapy (NET)

2020 ◽  
Vol 8 (1) ◽  
Author(s):  
Natalie R. Stevens ◽  
Michelle L. Miller ◽  
Christina Soibatian ◽  
Caitlin Otwell ◽  
Anne K. Rufa ◽  
...  
Keyword(s):  
Mental Health Treatment ◽  
Exposure Therapy ◽  
Case Series ◽  
Perinatal Outcomes ◽  
Post Treatment ◽  
Depression Symptoms ◽  
Narrative Exposure Therapy ◽  
Ptsd Treatment ◽  
Case Series Study ◽  
Increased Risk

Abstract Background Prenatal posttraumatic stress disorder (PTSD) is a significant complication of pregnancy linked to increased risk of adverse perinatal outcomes. Although 1 in 5 pregnant trauma-exposed individuals have PTSD, most PTSD treatment trials exclude participants who are pregnant, and none focus on treatment specifically during pregnancy. Moreover, access to mental health treatment is particularly challenging in low-resource settings with high rates of trauma. This study examined implementation of Narrative Exposure Therapy (NET), a short-term evidence-based PTSD treatment, in an urban prenatal care setting. Partial telehealth delivery was used to increase accessibility. Study aims were to examine (a) feasibility, (b) acceptability, and (c) case-based treatment outcomes associated with NET participation. Method Eight pregnant participants (median age = 27, median gestational week in pregnancy = 22.5) received up to six sessions of NET with partial telehealth delivery. PTSD and depression symptoms were assessed at pre-treatment intake (T1), at each session (T2), and 1-week post-treatment (T3). A multiple case study approach was used to examine recruitment and engagement, retention, treatment completion, treatment barriers, use of telehealth, participants’ experiences of treatment, and PTSD and depression symptoms. Results Nine of the 16 participants (56%) who were invited to participate engaged in treatment, and one dropped out after the first session. Eight participants completed the minimum “dose” of 4 NET sessions (N = 8/9, 89%). Seven participants gave the highest ratings of treatment acceptability. The most frequently reported barriers to treatment were competing priorities of work and caring for other children. Pre-post treatment symptom measures revealed clinically meaningful change in PTSD severity for nearly all participants (7/8, 88%). Conclusions Results suggest that a brief exposure therapy PTSD treatment can be successfully implemented during pregnancy, suggesting promising results for conducting a larger-scale investigation. Trial registration ClinicalTrials.gov, NCT04525469. Registered 20 August 2020–Retrospectively registered, https://register.clinicaltrials.gov/prs/app/template/EditRecord.vm?epmode=View&listmode=Edit&uid=U00058T2&ts=3&sid=S000A59A&cx=-w1vnvn

scholarly journals Buprenorphine/Naloxone Maintenance Therapy: an Observational Retrospective Report on the Effect of Dose on 18 months Retention in an Office-Based Treatment Program

2017 ◽  
Vol 11 ◽  
pp. 117822181773132
Author(s):  
Theodore V Parran ◽  
AG Mace ◽  
Yael J Dahan ◽  
Christopher A Adelman ◽  
Mykola Kolganov
Keyword(s):  
Treatment Program ◽  
Dose Range ◽  
Primary Care Clinic ◽  
Case Series ◽  
Funding Agency ◽  
Retrospective Report ◽  
Urban Hospital ◽  
Care Clinic ◽  
Patient Retention

Context and objective: Buprenorphine has been available with few reports of the dose range necessary to adequately maintain patients. We report on the effect of 8 mg/d versus 16 mg/d of buprenorphine on long-term patient retention in office-based opioid maintenance (OBOMT). Design, setting, and participants: Case series, at an urban hospital-based primary care clinic providing OBOMT to 157 opiate-dependent, low socioeconomic status, uninsured, nonhomeless patients. Intervention: The OBOMT program operated by a comprehensive sobriety treatment program experienced State funding cuts. Thus, after 2 years, the program was required by the State funder to decrease the buprenorphine maintenance dose from 16 to 8 mg/d for all new admissions. We report on patient retention before and after dose reduction. Main outcome measures: The primary outcomes of this study were to measure and compare patient retention in the 2 cohorts at each point of treatment transition over the 18 months following OBOMT initiation. Results: No significant differences in patient retention were observed between the 16 and 8 mg/d patient cohorts. Lower dose buprenorphine maintenance (8 mg/d) in uninsured patients enrolled in publicly funded long-term OBOMT combined with comprehensive sobriety counseling was as effective as higher dose therapy (16 mg/d) in promoting patient retention throughout the study period. This lower dose resulted in a substantial saving to the public funding agency. Conclusions: In an observational retrospective report, retention in treatment of opiate-addicted patients was the same at 8 and 16 mg/d buprenorphine doses after 18 months. These data have implications for public and managed care funding of OBOMT, for the general prescribing of buprenorphine in outpatient care, and may be instructive in the ongoing debate about the relationship between buprenorphine dose.

Predictors of change in cognitive processing therapy for veterans in a residential PTSD treatment program

2018 ◽  
Vol 75 (3) ◽  
pp. 364-379 ◽  
Author(s):  
Andrew C. Hale ◽  
Jessica L. Rodriguez ◽  
Theodore P. Wright ◽  
Scott A. Driesenga ◽  
C. Richard Spates
Keyword(s):  
Cognitive Processing ◽  
Treatment Program ◽  
Cognitive Processing Therapy ◽  
Ptsd Treatment ◽  
Predictors Of Change

Evaluation of an Integrative PTSD Treatment Program

2014 ◽  
Vol 20 (5) ◽  
pp. A11-A11
Author(s):  
Salvatore Libretto ◽  
Sandra Gordon ◽  
Lara Hilton ◽  
Courtney Lee ◽  
Weimin Zhang ◽  
...  
Keyword(s):  
Treatment Program ◽  
Ptsd Treatment

scholarly journals Intensive Dialectical Behavior Treatment for Individuals With Borderline Personality Disorder With and Without Substance Use Disorders

2021 ◽  
Vol 12 ◽  
Author(s):  
Frank D. Buono ◽  
Kaitlyn Larkin ◽  
David Rowe ◽  
M. Mercedes Perez-Rodriguez ◽  
Matthew E. Sprong ◽  
...  
Keyword(s):  
Substance Use ◽  
Borderline Personality Disorder ◽  
Personality Disorder ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Treatment Program ◽  
Coping Skills ◽  
Behavioral Therapy ◽  
Borderline Personality ◽  
Depression Symptom

Treatment of borderline personality disorder (BPD) with comorbid substance use disorder can be challenging due to symptom overlap and limited assessment methods. Preliminary evidence has shown promising effectiveness of dialectical behavioral therapy (DBT) for BPD with comorbid substance use disorders. The current study compared the benefits of a 28-day transitional DBT treatment program for individuals with BPD with and without substance use disorders through evaluating the changes in coping skills, generalized anxiety, and depression symptom scales at admission and discharge. A total of 76 patients were split into two groups: Group 1 consisted of individuals with BPD without substance use disorders (n = 41), and Group 2 involved individuals with BPD and a substance use disorder (SUD) (n = 35). A univariate general linear model showed significant differences between the two groups in improvement of coping skills and depressive symptoms. After a 28-day transitional DBT treatment program there were significant decreases from severe to moderate depression scores in both groups. Our findings support the effectiveness of DBT treatment in patients with comorbid BPD and SUD.

Comprehensive Treatment Program in a Case Series of Obstetrical Brachial Palsy Patients: Two years Outcome

PM&R ◽  
2013 ◽  
Vol 5 ◽  
pp. S201-S201
Author(s):  
Mercedes Martínez-Moreno ◽  
Florencio Jimenez-Martin ◽  
Ejessie Alfonso-Barrera ◽  
Sandra Espinosa ◽  
Susana Moraleda-Pérez
Keyword(s):  
Treatment Program ◽  
Case Series ◽  
Comprehensive Treatment
Sign in / Sign up

Export Citation Format

Share Document